Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010 and is headquartered in Novato, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
1,294
Frequently Asked Questions
What is Market Cap of Ultragenyx Pharmaceutical Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Ultragenyx Pharmaceutical Inc. market cap is $3.01B.
What is the 52-week high for Ultragenyx Pharmaceutical Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Ultragenyx Pharmaceutical Inc. 52 week high is $58.00 as of October 05, 2025.
What is the 52-week low for Ultragenyx Pharmaceutical Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Ultragenyx Pharmaceutical Inc. 52 week low is $25.81 as of October 05, 2025.
What is Ultragenyx Pharmaceutical Inc. stock price today?
Ultragenyx Pharmaceutical Inc. stock price today is $31.21.
What was Ultragenyx Pharmaceutical Inc. stock price yesterday?
Ultragenyx Pharmaceutical Inc. stock price yesterday was $30.90.
What is the PE ratio of Ultragenyx Pharmaceutical Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Ultragenyx Pharmaceutical Inc.’s P/E ratio is -5.65.
What is the Price-to-Book ratio of Ultragenyx Pharmaceutical Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Ultragenyx Pharmaceutical Inc. P/B ratio is 19.8418.
What is the 50-day moving average of Ultragenyx Pharmaceutical Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Ultragenyx Pharmaceutical Inc. 50-day moving average is $29.38.
How many employess does Ultragenyx Pharmaceutical Inc. has?
Ultragenyx Pharmaceutical Inc. has 1,294 employees.
